Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis. [electronic resource]
Producer: 20140512Description: 1623-30 p. digitalISSN:- 1744-7682
- Adolescent
- Arthritis, Juvenile -- drug therapy
- Biological Products -- adverse effects
- Child
- Child, Preschool
- Disease-Free Survival
- Double-Blind Method
- Etanercept
- Humans
- Immunoglobulin G -- adverse effects
- Infant
- Medication Adherence
- Multicenter Studies as Topic -- statistics & numerical data
- Neoplasms -- chemically induced
- Patient Preference
- Product Surveillance, Postmarketing
- Quality of Life
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Registries
- Remission Induction
- Sample Size
- Selection Bias
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.